Free Shipping on purchases over €100

Uriage Bariésun Unscented Spray SPF 50+ 200 ml

Bariésun unscented spray SPF 50+ 200 ml by Uriage is a formula that helps protect the skin of the face and body. It has an ultra protection technology that contributes to the creation of a barrier on the skin.

SKU: UR3661434008405
-8%
17.90
€19.50
€8.95
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Bariésun unscented spray SPF 50+ 200 ml Uriage is a product that contributes to the care and protection of the skin of the face and body. With a technology that provides ultra-protection, it is ideal for the care of the most sensitive skin.

The formula has combined a complex with high action filters and dermatological patents. This synergy helps prevent cellular damage and photo-ageing caused by blue light and UVB and UVA rays.

It has a very light texture that provides an invisible layer on the skin without leaving a sticky residue. This wellness content also has a high tolerance.

The product is equipped with Skin Shield technology. A blend of thermal spring water that helps protect DNA and the patented TELOMERES PROTECT that helps prevent cell damage.

The formula has the BARIESUN patent which helps to optimise protection. This patent helps to create a protective barrier against UV radiation.

The Uriage spray is also enriched with vitamin E and aguaspongines. These components are excellent preventive against antioxidants and dryness.

The protection product has an eco-friendly approach, the product formula has a formula that shows respect for the oceans. The packaging is of recyclable design.

Uriage's dermatologically tested formula is fragrance-free to contribute to better skin care.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.